title: PET applications in pediatrics.
abstract: This article summarizes the major PET studies which have been performed in pediatric patients to elucidate and characterize diseases and normal development. Issues special for the application of the technique in children, such as dosimetry, patient preparation, and image acquisition are discussed. Studies of central nervous system (CNS) development and pathology, including epilepsy, intraventricular hemorrhage, neonatal asphyxia, tumors, and effects on the CNS from treatment of other tumors are reviewed. These have contributed information fundamental to our understanding of CNS development and pathology. PET investigations into the pathophysiology of congenital heart disease have begun and hold great promise to aid our understanding of these conditions. The second major area in which PET has been applied is the study of non CNS neoplasms. Neuroblastoma has been investigated with tracers which explore basic biochemical features which characterize this tumor, as well as with tracers which explore biochemical events relatively specific for this malignancy. Other common and uncommon tumors of childhood are discussed. The PET technique has been shown useful for answering questions of clinical relevance for the management of these uncommon neoplasms. PET, using tracers that reflect basic metabolic processes, is likely to continue to aid our understanding of many pediatric diseases and may gain more widespread clinical acceptance as the technology continues to disseminate rapidly.
authors.affiliation: Pediatric Nuclear Medicine Section, University of Michigan Medical Center, Ann Arbor 48109-0229, USA.
authors.forename: B L
authors.initials: BL
authors.lastname: Shulkin
mesh_terms: D002493:Central Nervous System Diseases / Q000000981:diagnostic imaging*; D002648:Child; D002675:Child, Preschool; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006330:Heart Defects, Congenital / Q000000981:diagnostic imaging*; D006801:Humans; D007223:Infant; D009369:Neoplasms / Q000000981:diagnostic imaging*; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18